Jon A Norman

Title: Innovations in Lyme Disease Vaccines by Jon A Norman

Introduction

Jon A Norman is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of vaccine development. He holds 2 patents that focus on innovative methods for combating Lyme Disease, a condition caused by the Borrelia bacteria.

Latest Patents

Norman's latest patents include groundbreaking compositions and methods for administering Borrelia DNA. One patent discloses a vaccine against Lyme Disease that contains a plasmid DNA encoding various components essential for eliciting an immune response. This includes a promoter for driving expression in mammalian cells, a leader peptide for facilitating the secretion of prokaryotic proteins, and DNA encoding Borrelia antigens such as OspA, OspB, and OspC. The immunogenic compositions are designed to generate protective responses in hosts susceptible to Lyme Disease. Another patent focuses on plasmid DNA encoding at least one Borrelia genospecies antigen, which can be used for in vivo responses or for generating antibodies in vitro.

Career Highlights

Throughout his career, Jon A Norman has worked with notable companies in the biotechnology sector, including Pasteur Merieux Serums Et Vaccins and Vical Incorporated. His work has significantly advanced the understanding and treatment of Lyme Disease through innovative vaccine development.

Collaborations

Norman has collaborated with esteemed colleagues such as Robert C Huebner and Xiaowu Liang, contributing to the collective effort in vaccine research and development.

Conclusion

Jon A Norman's innovative work in the field of Lyme Disease vaccines showcases his dedication to improving public health through scientific advancements. His patents reflect a commitment to developing effective immunological solutions against this challenging disease.